<DOC>
	<DOCNO>NCT01573026</DOCNO>
	<brief_summary>The purpose research study document use Keystone Dental Genesis Dental Implant System standard clinical use provide 5 year survival data .</brief_summary>
	<brief_title>Five Year Survival Study Evaluating Genesis Dental Implant System</brief_title>
	<detailed_description>The technology behind dental implant well establish Genesis Dental Implant System clear marketing FDA . It Keystone Dental 's choice collect post-market data within framework clinical trial order assess clinical performance device . The risk Genesis Dental Implant System different comparable dental implant system currently use . Keystone Dental expect clinical performance device equal comparable implant system . The purpose research study assess 5 year survival rate Genesis Dental Implant System , well assess safety effectiveness endpoint , include incidence adverse effect , change bone height soft tissue aesthetic outcome .</detailed_description>
	<criteria>Subject must 18 85 year old , inclusive , passed growth maximum time implant placement Subject must willing sign inform consent document adhere study procedure . Subject must one natural teeth miss extract . Subject must fulfill accept medical dental requirement treatment dental implant . Subject must desire treatment dental implant . Subject refuse sign informed consent document . Subject 's treatment success clinical esthetic measure may compromise restricted range product available study . The treatment plan use range product available best interest subject . Please see Section 1.2.1 restriction product availability . The implant site ( ) previously fail implant . Subject treat within restriction treatment plan lay Section 5 . In addition , please see Section 1.2.1 restriction product availability . Subject alveolar ridge dimension sufficient accommodate sustain proper implant placement . Subject communicable understandable language . Current Alcohol Drug Abuse ( within previous 12 month ) note subject 's chart . Women pregnant time enrollment study . Subject control metabolic disease . Subject chemotherapy long term cortisone use ( time ) . Subject know allergy titanium . Subject diabetes . Subject history autoimmune disease ( e.g . document multiple allergy , systemic lupus erythematosus , dermatomyositis , etc . ) immunosuppressive disease ( e.g . human immunodeficiency virus acquire immunodeficiency syndrome ) . Subject epilepsy . Subjects uncontrolled severe case hyperthyroidism , malignancy , renal disease , liver problem , hypertension , leukemia , severe vascular heart disease , hepatitis , collagen bone disease , serious illness . Subject currently take bisphosphonate calcium channel blocker . There reasonable doubt subject comply recall schedule . There reasonable doubt subject comply clinician ' instruction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Dental Implants</keyword>
	<keyword>Dental Implantation</keyword>
	<keyword>Osseointegration</keyword>
</DOC>